Skip to Main Content

Paper Details

Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trial.
Int J Stroke
23
2022
Author NameAffiliation
Jordan J ElmMedical University of South Carolina
Pooja KhatriUniversity of Cincinnati
Joseph P BroderickUniversity of Cincinnati
  • 1 - 3

Datasets

Release 1.2